Dermatology OTC Medications Global Market Report 2024

Description

Dermatology over-the-counter (OTC) medications are non-prescription drugs designed for the prevention and treatment of conditions affecting the skin, hair, nails, mouth, and genitalia. These medications are safely and effectively used by the public without the need for consultation with a healthcare practitioner.

The primary forms of dermatology OTC medications include tablets and capsules, oils, gels, creams, ointments, and other formulations. Tablets are solid dosage forms containing drugs, either with or without excipients, while capsules are solid pharmaceutical dosage forms enclosed in a gelatin shell or a suitable material, offering a variety of shapes. An example of an over-the-counter medication is cetirizine, used to address allergy symptoms such as itchy eyes. Dermatology OTC medications are employed to treat various conditions, including dermatitis, acne, psoriasis, skin bleaching, anti-fungal treatments, wart removal, and others. These medications are primarily administered through topical and oral routes and are made available through distribution channels such as online and offline retail outlets.

The dermatology OTC medications market research report is one of a series of new reports from The Business Research Company that provides dermatology OTC medications statistics, including the dermatology OTC medications industry global market size, regional shares, competitors with a dermatology OTC medications market share, detailed dermatology OTC medications market segments, market trends, and opportunities, and any further data you may need to thrive in the dermatology OTC medications industry. This dermatology OTC medications market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The dermatology otc medications market size has grown steadily in recent years. It will grow from $15.32 billion in 2023 to $15.96 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The expansion observed in the historical period can be ascribed to regulatory changes, a desire for convenience, the impact of skincare trends, consumer-driven demand, as well as marketing and advertising efforts.

The dermatology otc medications market size is expected to see steady growth in the next few years. It will grow to $19.06 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The anticipated growth in the forecast period can be credited to increasing awareness of skin health, a growing global aging population, environmental factors, a focus on sustainability and clean beauty, as well as the adoption of telemedicine and remote consultation. Key trends expected in the forecast period encompass the emergence of niche condition-specific products, the popularity of gender-neutral skincare, the prevalence of multi-functional products, the promotion of microbiome-friendly skincare, and the introduction of CBD-infused products.

The anticipated increase in skin abnormalities is expected to drive the growth of the dermatology over-the-counter (OTC) medication market in the future. Skin abnormalities refer to unusual skin lesions or appearances, and OTC drugs in dermatology are utilized to treat such abnormalities and restore skin to a normal state. The demand for over-the-counter dermatology medications is on the rise due to the growing need for treating various skin abnormalities, including conditions such as psoriasis. For example, as of August 2021, the Centers for Disease Control (CDC) reported that more than 7.5 million people in the USA and over 125 million people globally were affected by psoriasis, a prevalent chronic cutaneous dermatitis. Hence, the surge in skin abnormalities is a significant factor propelling the growth of the dermatology OTC medication market.

The expansion of e-commerce is playing a substantial role in driving the growth of the dermatology OTC medications market in the foreseeable future. E-commerce, which involves the online buying and selling of goods and services over the internet, enables dermatology OTC medication brands to broaden their market reach beyond local boundaries. This platform allows companies to market and sell their products to a global audience, providing access to consumers who may not have availability to specific products through traditional retail channels. For instance, according to the 2023 data released by the United States Census Bureau, e-commerce sales witnessed a 7.6 percent increase from the third quarter of 2022 to the third quarter of 2023. Therefore, the expansion of e-commerce and online pharmacies is poised to drive the dermatology OTC medications market.

Prominent companies in the dermatology over-the-counter (OTC) medications market are actively introducing innovative drugs, such as anti-fungal treatment solutions, to enhance their market profitability. An example of this is Bayer AG, a Germany-based pharmaceutical company, which launched Canesten in May 2022. Canesten, available in various forms such as cream, topical solution, and combination products, serves as an antifungal medication. It is designed to treat fungal skin infections, including vaginal thrush, ringworm, athlete's foot, diaper rash, and sweat rash. The active ingredient in Canesten products is clotrimazole, an antifungal agent that both kills and prevents the growth of fungus. Notably, Canesten is an over-the-counter (OTC) medication considered generally safe for use during pregnancy or while nursing.

Major players in the dermatology OTC medications market are strategically emphasizing the development of sustainable and clean offerings to attract customers. With consumers increasingly prioritizing environmentally friendly skincare solutions, companies are incorporating elements such as eco-friendly packaging, cruelty-free formulations, and minimal environmental impact. An illustration of this trend is seen in the initiative by the Honest Company, a US-based personal skincare products company, which introduced sustainable beauty packaging for its skincare products in July 2021. The initiative involved updating over 100 skincare units (SKUs) to use 100% recyclable cartons made from upcycled sugarcane byproduct. Changes to primary packaging, such as glass droppers, aluminum tubes, tin compacts, PCR materials, and mono-material components, aimed to utilize more environmentally friendly materials.

In February 2022, Taro Pharmaceutical Industries Ltd., a US-based pharmaceutical company, acquired Alchemee for an undisclosed amount. This strategic move positions Taro to strengthen its presence in the over-the-counter dermatology market by incorporating Alchemee's assets and resources, including the Proactiv brand. Additionally, Taro gains access to Alchemee's team expertise in omnichannel marketing. Alchemee, a US-based health, wellness, and fitness company specializing in skin health, direct marketing, and acne, enhances Taro's capabilities in the dermatology OTC medications market.

Major companies operating in the dermatology otc medications market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Bristol Myers Squibb Co, GlaxoSmithKline PLC, Acella Pharmaceuticals LLC, Eli Lilly and Company, Amgen Inc., Allergan PLC, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Inc., Perrigo Company PLC, Galderma S.A., Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Inc., Lupin Limited, LEO Pharma A/S, Almirall S.A., Concert Pharmaceuticals, Arcutis Biotherapeutics, Dermavant Sciences, Roivant Sciences Inc

North America was the largest region in the dermatology OTC medications market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermatology otc medications market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dermatology otc medications market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dermatology OTC medication market consists of sales of roasted moisturizers, shampoo, and acne products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dermatology OTC Medications Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dermatology otc medications market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dermatology otc medications ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dermatology otc medications market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Tablets And Capsules; Oils Gels; Creams And Ointments; Other Types
2) By Indication: Dermatitis; Acne; Psoriasis; Skin Bleaching; Anti-Fungal; Wart Remover; Other Indications
3) By Route Of Administration: Topical; Oral
4) By Distribution Channel: Online Distribution; Offline Distribution
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13620

1. Executive Summary

2. Dermatology OTC Medications Market Characteristics

3. Dermatology OTC Medications Market Trends And Strategies

4. Dermatology OTC Medications Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Dermatology OTC Medications Market Size and Growth

5.1. Global Dermatology OTC Medications Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Dermatology OTC Medications Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Dermatology OTC Medications Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Dermatology OTC Medications Market Segmentation

6.1. Global Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Tablets And Capsules
Oils Gels
Creams And Ointments
Other Types
6.2. Global Dermatology OTC Medications Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Dermatitis
Acne
Psoriasis
Skin Bleaching
Anti-Fungal
Wart Remover
Other Indications
6.3. Global Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Topical
Oral
6.4. Global Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Online Distribution
Offline Distribution

7. Dermatology OTC Medications Market Regional And Country Analysis

7.1. Global Dermatology OTC Medications Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Dermatology OTC Medications Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Dermatology OTC Medications Market

8.1. Asia-Pacific Dermatology OTC Medications Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Dermatology OTC Medications Market

9.1. China Dermatology OTC Medications Market Overview
9.2. China Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Dermatology OTC Medications Market

10.1. India Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Dermatology OTC Medications Market

11.1. Japan Dermatology OTC Medications Market Overview
11.2. Japan Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Dermatology OTC Medications Market

12.1. Australia Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Dermatology OTC Medications Market

13.1. Indonesia Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Dermatology OTC Medications Market

14.1. South Korea Dermatology OTC Medications Market Overview
14.2. South Korea Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Dermatology OTC Medications Market

15.1. Western Europe Dermatology OTC Medications Market Overview
15.2. Western Europe Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Dermatology OTC Medications Market

16.1. UK Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Dermatology OTC Medications Market

17.1. Germany Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Dermatology OTC Medications Market

18.1. France Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Dermatology OTC Medications Market

19.1. Italy Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Dermatology OTC Medications Market

20.1. Spain Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Dermatology OTC Medications Market

21.1. Eastern Europe Dermatology OTC Medications Market Overview
21.2. Eastern Europe Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Dermatology OTC Medications Market

22.1. Russia Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Dermatology OTC Medications Market

23.1. North America Dermatology OTC Medications Market Overview
23.2. North America Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Dermatology OTC Medications Market

24.1. USA Dermatology OTC Medications Market Overview
24.2. USA Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Dermatology OTC Medications Market

25.1. Canada Dermatology OTC Medications Market Overview
25.2. Canada Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Dermatology OTC Medications Market

26.1. South America Dermatology OTC Medications Market Overview
26.2. South America Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Dermatology OTC Medications Market

27.1. Brazil Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Dermatology OTC Medications Market

28.1. Middle East Dermatology OTC Medications Market Overview
28.2. Middle East Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Dermatology OTC Medications Market

29.1. Africa Dermatology OTC Medications Market Overview
29.2. Africa Dermatology OTC Medications Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Dermatology OTC Medications Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Dermatology OTC Medications Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Dermatology OTC Medications Market Competitive Landscape And Company Profiles

30.1. Dermatology OTC Medications Market Competitive Landscape
30.2. Dermatology OTC Medications Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. AbbVie Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Bayer AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Novartis AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Dermatology OTC Medications Market Other Major And Innovative Companies

31.1. Bristol Myers Squibb Co
31.2. GlaxoSmithKline Plc
31.3. Acella Pharmaceuticals LLC
31.4. Eli Lilly and Company
31.5. Amgen Inc.
31.6. Allergan plc
31.7. Viatris Inc.
31.8. Teva Pharmaceutical Industries Ltd.
31.9. Mylan N.V.
31.10. Astellas Pharma Inc.
31.11. Bausch Health Companies Inc.
31.12. Sun Pharmaceutical Industries Inc.
31.13. Perrigo Company PLC
31.14. Galderma S.A.
31.15. Dr. Reddy's Laboratories Ltd.

32. Global Dermatology OTC Medications Market Competitive Benchmarking

33. Global Dermatology OTC Medications Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Dermatology OTC Medications Market

35. Dermatology OTC Medications Market Future Outlook and Potential Analysis

35.1 Dermatology OTC Medications Market In 2028 - Countries Offering Most New Opportunities
35.2 Dermatology OTC Medications Market In 2028 - Segments Offering Most New Opportunities
35.3 Dermatology OTC Medications Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer